What Theranos taught investors about commercialization in health care, MarketWatch by Matthew McCooe, Connecticut Innovations
Matthew McCooe’s piece deconstructs the effects of the Theranos fallout, translating what is easily viewed as an obstacle into a horizon of opportunity for investors. The lesson here points to the need to find better ways to protect investment bets, and in bioscience, research reproducibility is key. By exemplifying the critical importance of research verification, Matthew offers specific bioscience investment strategies vital to the due diligence process.